Digestive System Diseases

633 trials 301 recruiting

Filter these 633 trials by phase, country and sponsor.

Open in Search →

Effect of obesity due to the action of aspirin and its effectiveness in therapy for the treatment of colon cancer. Recruiting

2024-515251-37-00 Colorectal cancer 4 2024-11-05
Continuous Wound Infiltration versus placebo following elective minimally invasive colorectal surgery; a double-blinded, randomised, placebo… Recruiting

2024-512107-39-00 Recovery following elective minimally invasive colorect 5 2024-10-30
A Long-term Extension Study of Guselkumab in Pediatric Participants Recruiting

2023-509560-16-00 Juvenile psoriatic arthritis (jPsA) 5 2024-10-29
PHASE III RANDOMIZED STUDY OF FOLFOXIRI PLUS BEVACIZUMAB AND ATEZOLIZUMAB VERSUS FOLFOXIRI PLUS BEVACIZUMAB AS FIRST-LINE TREATMENT OF UNRES… Recruiting

2023-506632-32-00 Metastatic colorectal cancer 5 2024-10-28
Preventing liver recurrence after partial hepatectomy for intrahepatic cholangiocarcinoma using adjuvant hepatic arterial infusion pump chem… Recruiting

2024-513726-33-00 Intrahepatic cholangiocarcinoma (iCCA) 4 2024-10-25
Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN’s … Recruiting

2024-517794-24-00 crohn disease 4 2024-10-24
Local Levobupivacaine for pain reflief after esophageal ESD Recruiting

2024-510912-66-00 Visible esophageal lesions ((pre)cancerous) 6 2024-10-22
Remimazolam versus Midazolam for sedation during upper GI endoscopy: a randomized controlled trial Recruiting

2024-516432-94-00 N/A 6 2024-10-21
Short-term interruption versus continuous anticoagulation in colorectal polypectomy. A randomized multicenter investigator-initiated non-inf… Recruiting

2024-512194-27-01 Patients receiving oral anticoagulant therapy who are s 6 2024-10-21
PERi-operative Selective Decontamination of the Digestive tract to prevent severe infectious complications after Esophagectomy: a Randomized… Recruiting

2023-504144-33-01 esophageal cancer 11 2024-10-17
Clinical trial with MBK-01, intestinal microbiota capsules, for the treatment of patients with recurring diverticulitis Recruiting

2023-506224-87-00 Recurring diverticulitis 4 2024-10-14
Tittle: Effects of intravenous administered iron in non-anemic iron deficient patients with colorectal cancer. A double blinded clinical ran… Recruiting

2024-518517-26-00 Iron deficiency 4 2024-10-10
Repairing Peri-Anal Fistulas with regenerative cell therapeutics (REP-PAF) Recruiting

2022-502659-73-01 Crypto-glandular perianal fistula 7 2024-10-09
This is a multicenter, double-blind, randomized study to compare the safety, effectiveness and immunogenicity (level and body resistance to … Recruiting

2023-509775-16-00 Ulcerative colitis 4 2024-10-03
Analgesic effect of intravenous lidocaïne and its mechanisms in patients suffering from chronic inflammatory bowel disease (IBD) with abdomi… Recruiting

2023-508224-35-01 Inflammatory Bowel disease 4 2024-09-30
A combined treatment with GM-CSF, fosfomycin and metronidazole for pouchitis in ulcerative colitis patients after restorative ileal pouch an… Recruiting

2024-517764-38-00 Pouchitis 9 2024-09-27
tislelizUMaB in canceR patients with molEcuLar residuaL disease (UMBRELLA) Recruiting

2023-503316-33-00 patients with a positive status for molecular residual 5 2024-09-26
PRODIGE 98- AMPIRINOX : Randomized, multicenter, Phase III trial of adjuvant chemotherapy with modified FOLFIRINOX versus capecitabine or ge… Recruiting

2024-511070-68-01 Ampullary adenocarcinoma 5 2024-09-24
FREE-study Recruiting

2024-516277-68-00 Crohn's disease Ulcerative colitis 6 2024-09-19
Personalized dosing of FOLFIRINOX in pancreatic cancer patients: a phase-2 pharmacokinetic, safety and feasibility trial Recruiting

2024-510576-21-00 Pancreatic cancer 4 2024-09-18
A trial to evaluate the efficacy and safety of oral controlled-ileocolonic-release nicotinamide (CICR-NAM) in patients with mild to moderate… Recruiting

2024-510807-13-00 ulcerative colitis 10 2024-09-12
FLUOCOL-1 : Intraoperative Indocyanine Green Fluorescence Angiography in Colorectal Surgery to Prevent Anastomotic Leakage Recruiting

2024-515118-42-00 Colorectal cancer 11 2024-09-10
Semaglutide Treatment for Prevention of Toxicity in High-dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation Recruiting

2022-502139-20-00 Mucositis and systemical inflammation, which is a treat 4 2024-09-09
A Phase 2b Study to Evaluate the Efficacy and Safety of Oral TAK-279 in Subjects with Moderately to Severely Active Crohn’s Disease Recruiting

2023-506704-14-00 Moderately to Severely Active Crohn's Disease 4 2024-09-04